Martek, Abbott, Bristol-Myers sales and marketing update

ABT's Ross Products Division plans to launch in the U.S. early this year an infant formula that contains MATK's docosahexaenoic acid (DHA) and arachidonic acid (ARA), long-chain polyunsaturated fatty acids. ABT has a non-exclusive license to ARA and DHA under a 2000 deal (see BioCentury, April 10, 2000). ...